NO771860L - P}visning av kreft. - Google Patents
P}visning av kreft.Info
- Publication number
- NO771860L NO771860L NO771860A NO771860A NO771860L NO 771860 L NO771860 L NO 771860L NO 771860 A NO771860 A NO 771860A NO 771860 A NO771860 A NO 771860A NO 771860 L NO771860 L NO 771860L
- Authority
- NO
- Norway
- Prior art keywords
- cancer
- tumor
- malignant melanoma
- extract
- patients
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5751—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the skin, e.g. melanoma
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5752—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the lungs
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57525—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the liver or pancreas
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57545—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the ovaries
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5755—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the uterine cervix, uterine corpus or endometrium
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69045476A | 1976-05-27 | 1976-05-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO771860L true NO771860L (no) | 1977-11-29 |
Family
ID=24772522
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO771860A NO771860L (no) | 1976-05-27 | 1977-05-26 | P}visning av kreft. |
Country Status (18)
| Country | Link |
|---|---|
| JP (1) | JPS52145517A (da) |
| AT (1) | AT357690B (da) |
| AU (1) | AU506539B2 (da) |
| BE (1) | BE855063A (da) |
| DE (1) | DE2724114A1 (da) |
| DK (1) | DK233277A (da) |
| ES (1) | ES459164A1 (da) |
| FI (1) | FI771646A7 (da) |
| FR (1) | FR2352533A1 (da) |
| GB (1) | GB1520208A (da) |
| IE (1) | IE45284B1 (da) |
| IL (1) | IL52133A0 (da) |
| LU (1) | LU77413A1 (da) |
| NL (1) | NL7705873A (da) |
| NO (1) | NO771860L (da) |
| NZ (1) | NZ184159A (da) |
| SE (1) | SE7706203L (da) |
| ZA (1) | ZA773026B (da) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3999944A (en) * | 1975-02-28 | 1976-12-28 | Hoffmann-La Roche Inc. | Detection of breast cancer |
| US4043757A (en) * | 1975-05-20 | 1977-08-23 | Ortho Pharmaceutical Corporation | Method for detection of human mammary carcinoma |
-
1977
- 1977-05-20 AU AU25341/77A patent/AU506539B2/en not_active Expired
- 1977-05-20 NZ NZ184159A patent/NZ184159A/xx unknown
- 1977-05-20 ZA ZA00773026A patent/ZA773026B/xx unknown
- 1977-05-20 IL IL52133A patent/IL52133A0/xx unknown
- 1977-05-24 FI FI771646A patent/FI771646A7/fi not_active Application Discontinuation
- 1977-05-24 IE IE1055/77A patent/IE45284B1/en unknown
- 1977-05-25 JP JP6000577A patent/JPS52145517A/ja active Pending
- 1977-05-25 FR FR7715965A patent/FR2352533A1/fr active Granted
- 1977-05-25 LU LU77413A patent/LU77413A1/xx unknown
- 1977-05-26 NO NO771860A patent/NO771860L/no unknown
- 1977-05-26 AT AT376977A patent/AT357690B/de not_active IP Right Cessation
- 1977-05-26 GB GB22283/77A patent/GB1520208A/en not_active Expired
- 1977-05-26 BE BE177925A patent/BE855063A/xx unknown
- 1977-05-26 SE SE7706203A patent/SE7706203L/ not_active Application Discontinuation
- 1977-05-26 DK DK233277A patent/DK233277A/da not_active Application Discontinuation
- 1977-05-26 ES ES459164A patent/ES459164A1/es not_active Expired
- 1977-05-27 NL NL7705873A patent/NL7705873A/xx not_active Application Discontinuation
- 1977-05-27 DE DE19772724114 patent/DE2724114A1/de not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| NL7705873A (nl) | 1977-11-29 |
| GB1520208A (en) | 1978-08-02 |
| DK233277A (da) | 1977-11-28 |
| AU506539B2 (en) | 1980-01-10 |
| ATA376977A (de) | 1979-12-15 |
| FI771646A7 (da) | 1977-11-28 |
| BE855063A (fr) | 1977-11-28 |
| AU2534177A (en) | 1978-11-23 |
| NZ184159A (en) | 1979-03-28 |
| SE7706203L (sv) | 1977-11-28 |
| DE2724114A1 (de) | 1977-12-15 |
| IE45284B1 (en) | 1982-07-28 |
| IL52133A0 (en) | 1977-07-31 |
| ES459164A1 (es) | 1978-04-16 |
| LU77413A1 (da) | 1978-06-26 |
| FR2352533B1 (da) | 1980-06-13 |
| FR2352533A1 (fr) | 1977-12-23 |
| ZA773026B (en) | 1978-04-26 |
| AT357690B (de) | 1980-07-25 |
| IE45284L (en) | 1977-11-27 |
| JPS52145517A (en) | 1977-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Muna et al. | Detection by immunofluorescenge of antibodies specific for human malignant melanoma cells | |
| Weller et al. | Fluorescent antibody studies with agents of varicella and herpes zoster propagated in vitro. | |
| US3999944A (en) | Detection of breast cancer | |
| BJÖRKLUND | Tissue Polypeptide Antigen (TТРА): Biology, Biochemistry, Improved Assay Methodology, Clinical Significance in Cancer and Other Conditions | |
| CA1045031A (en) | Serological test for gonorrheal antibodies | |
| Amino et al. | Immunologic aspects of human thyroid cancer. Humoral and cell‐mediated immunity, and a trial of immunotherapy | |
| Hollinshead et al. | Reactivity between herpesvirus type 2-related soluble cervical tumor cell membrane antigens and matched cancer and control sera | |
| Mohos et al. | Insulin-induced glomerulosclerosis in the rabbit | |
| Friedman et al. | A hemagglutination test for detection of adenovirus antibodies | |
| Guinan et al. | Urinary carcinoembryonic-like antigen levels in patients with bladder carcinoma | |
| Poskitt et al. | Renal deposition of soluble immune complexes in mice bearing B-16 melanoma: Characterization of complexes and relationship to tumor progress | |
| CN108948185B (zh) | 蒜氨酸抗原及其免疫应答获得的家兔蒜氨酸抗体 | |
| Braathen et al. | Evidence for Fc IgG receptors and complement factor C3b receptors in human choroid plexus | |
| Badger et al. | Immunosuppressive activity and tissue polypeptide antigen content of human ascitic fluids | |
| Elias et al. | Cellular immunity in patients with colorectal adenocarcinoma measured by autologous leukocyte migration inhibition | |
| US3992516A (en) | Direct fluorescent antibody composition and method for P. Pneumocystis carinii | |
| Schultz et al. | Glomerular disease in two patients with urticaria-cutaneous vasculitis and hypocomplementemia | |
| NO771860L (no) | P}visning av kreft. | |
| Goodwin et al. | Immune responses induced by human malignant melanoma in the rabbit | |
| Ilfeld et al. | IgG monoclonal gammopathy in four patients with polymyalgia rheumatica | |
| Baer et al. | The immunology and chemistry of tuberculin: I. The isolation of dialyzable and nondialyzable tuberculin-active components from unheated BCG culture filtrates | |
| Nelson | Antigens of carcinoma of the cervix uteri. A study by means of immunofluorescence | |
| Runge et al. | In vivo and in vitro responses to autologous IgG in patients with rheumatoid arthritis | |
| Walters et al. | Specific cell‐mediated immunity in the laboratory diagnosis of dermatophytic infections | |
| Pesce et al. | Immune complexes in transitional cell carcinoma |